BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

HEMOSYSTEM® SA 

45 Cours Gouffé

Marseille    13006  France
Phone: 33-4-96-20-29-70 Fax: +33-4-96-20-29-99


SEARCH JOBS


(a) HEMOSYSTEM is a biotechnology company devoted to the transfusion medicine. It's projects address the major transfusion issues : security and efficacy of blood products.

(b) Transfusion safety, Hemosystem has developed a rare event detector technology, ScanSystem(tm) for the detection of bacteria in blood products on a routine basis for screening blood donor components prior to transfusion. The method uses together a specific disposable to prepare the sample and a simple and rapid scanning device for solid phase cytometry able to detect a low number of fluorescent cells. HemoSystem develops also a simple and low cost method for the detection of leucocytes in blood products.

(c) Transfusion efficacy, Hemosystem is developing an additive solution to be added in blood components, able to extend their in vitro life span by 50%. This additive will be used to increase storage time for both platelets and red blood cells and to protect red blood cells during gamma irradiation, also improving their quality.

This additive is a naturally occurring substance that transports long chain fatty acids across cell membranes, improving cell membrane stability and preventing membrane ageing.

Product Names / Compound Descriptions:
ScanSystem™ (analyzer technology) and Lifesol™ (blood storage additive).

Target Indications:
Hemosystem's vocation is to improve safety in the blood transfusion field, offering their range of products designed for this purpose to the different international blood transfusion systems.

Key Management Names and Titles:

Jean-Pierre HERMET - President & Chief Executive Officer jeanpierrehermet@hemosystem.com

Géraldine FRANKIDJIAN - Chief Financial Officer gfrankidjian@hemosystem.com

Isabelle BESSON-FAURE - Hematology Project Director ibesson_faure@hemosystem.com

Anne MONNOT DES ANGLES - Microbiology Project Director amonnot@hemosystem

Last Updated: 2-28-02


 Key Statistics


Email: hemosystem@hemosystem.com
Ownership:

Web Site: HEMOSYSTEM® SA
Employees: 10 (15 by the end of the year)
Symbol: 
 



Industry
Biotechnology


Collaborations

Chemunex SA  exclusive worldwide license related to analyzer technology in the blood transfusion field

Ortho Neutrogena  scientific collaboration agreement for bacteria detection technology

Sigma-Tau Pharmaceuticals  exclusive worldwide license for L-carnitine patents related to the blood transfusion field





 Company News